Alert detail
LCD L40199 (Notice Ends 08/09/2026): MolDX: Biomarker Testing in Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis — CGS Administrators
What changed
New MolDX LCD for MASLD/MASH biomarker tests effective Aug 2026.
Who’s affected: Clinical Laboratory billing teams · Effective: August 10, 2026
Primary source: View the official CMS/MAC document ↗
Get the action steps and full analysis
This change affects 12 billing codes.
The full analysis, the revision comparison and the as-of-date version of this policy are what a partner packet carries. The source document above is free and always will be.